Trade Summary

4 days ago, Patel Snehal, serving as CEO and CFO at Greenwich LifeSciences, Inc. (GLSI), purchased 3,600 shares at $13.06 per share, for a total transaction value of $47,018.00. Following this transaction, Patel Snehal now holds 5,607,702 shares of GLSI.

This purchase represents a 0.06% increase in Patel Snehal's stake in the company.

The trade was executed on Thursday, July 23, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 27, 2026 at 6:15 AM ET, 4 days after the trade was made.

Greenwich LifeSciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.